CD2 Monoclonal Antibody(3F3)

The protein encoded by this gene is a surface antigen found on all peripheral blood T-cells. The encoded protein interacts with LFA3 (CD58) on antigen presenting cells to optimize immune recognition. A locus control region (LCR) has been found in the 3' flanking sequence of this gene.

Introducing the CD2 Monoclonal Antibody (3F3), a cutting-edge product designed to revolutionize the field of immunology. This highly advanced antibody is meticulously engineered to specifically target and bind to the CD2 antigen, a crucial cell surface marker found on T lymphocytes.

The CD2 Monoclonal Antibody (3F3) boasts exceptional specificity and affinity, ensuring precise and efficient recognition of the CD2 antigen. Its monoclonal nature guarantees consistent and reliable performance, making it an invaluable tool for researchers and clinicians alike.

With its superior binding capabilities, the CD2 Monoclonal Antibody (3F3) enables a wide range of applications in immunological research and diagnostics. It can be utilized for flow cytometry, immunohistochemistry, and immunofluorescence assays, providing accurate and detailed analysis of CD2 expression in various biological samples.

Furthermore, the CD2 Monoclonal Antibody (3F3) exhibits exceptional stability and durability, ensuring long-lasting and reproducible results. Its formulation is optimized to minimize non-specific binding, reducing background noise and enhancing signal-to-noise ratios.

This groundbreaking product is manufactured under stringent quality control measures, adhering to the highest industry standards. Each batch undergoes rigorous testing to guarantee purity, potency, and consistency, ensuring optimal performance and reliability.

In summary, the CD2 Monoclonal Antibody (3F3) is a state-of-the-art immunological tool that offers unparalleled specificity, reliability, and versatility. Its exceptional binding capabilities and robust performance make it an indispensable asset for researchers and clinicians seeking to unravel the complexities of CD2 expression and its implications in various disease states.